Cepacol
Pricing Report NDC 63824-730-16

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Cepacol Sore Throat (NDC 63824-730-16) is $0.14704 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 18, 2020.

As a provided by Rb Health (us) Llc, this medication is distributed in a 2 BLISTER PACK in 1 CARTON / 8 LOZENGE in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.14704
Per EA

Effective Date
Mar 18, 2020
Billable Units
2 EA
Estimated Package Price
$0.29
Data Status
As of Aug 05, 2020
C/I - Chain or Independent Pharmacy
Package NDC
Description
2 BLISTER PACK in 1 CARTON / 8 LOZENGE in 1 BLISTER PACK
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.14178 to $0.16188 per EA. Over this 6 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1418 - $0.1619
Market Volatility
14.18% Variance
Latest Trend
2.19%
Date Unit Price Unit Source Method Rate
Mar 18, 2020 $0.14704 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 18, 2020 $0.14704 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Nov 20, 2019 $0.14389 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 20, 2019 $0.14389 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Nov 20, 2019 $0.14389 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Oct 23, 2019 $0.15113 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 18, 2019 $0.14670 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 19, 2017 $0.15568 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 19, 2017 $0.15568 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jul 19, 2017 $0.15568 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 22, 2017 $0.15163 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 22, 2017 $0.15163 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jan 18, 2017 $0.14585 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 18, 2017 $0.14585 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Dec 21, 2016 $0.15467 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 23, 2016 $0.14178 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 22, 2016 $0.15403 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 22, 2016 $0.15403 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Apr 20, 2016 $0.15097 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 20, 2016 $0.15097 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Mar 23, 2016 $0.15509 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 17, 2016 $0.14523 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 18, 2015 $0.14851 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 18, 2015 $0.14851 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Oct 21, 2015 $0.15417 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 23, 2015 $0.16188 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 01, 2015 $0.16016 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jul 01, 2015 $0.16016 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Jun 17, 2015 $0.15684 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 22, 2015 $0.15374 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 22, 2015 $0.15374 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Nov 19, 2014 $0.14963 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 19, 2014 $0.14963 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Nov 19, 2014 $0.14963 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Oct 22, 2014 $0.15290 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 17, 2014 $0.15289 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 18, 2014 $0.14838 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 18, 2014 $0.14838 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jun 18, 2014 $0.14838 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
May 23, 2013 $0.14881 EAC/I - Chain or Independent PharmacyCode 4B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026